AIM ImmunoTech AIM
NYSE AIM
$0.18 -0.01 (-5.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

AIM ImmunoTech (AIM) Gains from Investment Securities (2011)

Updated

AIM ImmunoTech (AIM) reported Gains from Investment Securities of $145,000 for FY2014, down 81.9% from $800,000 in FY2013.

Analysis

AIM ImmunoTech (AIM) Gains from Investment Securities (2011) Analysis & Trends

Dating back to FY2011, AIM ImmunoTech's Gains from Investment Securities record includes 4 years.

  • Gains from Investment Securities has a three-year compound annual growth rate of 28.1% (FY2011 to FY2014).
  • Five-year annual Gains from Investment Securities spans a low of $9,000 in FY2012 and a high of $800,000 in FY2013.
  • According to Business Quant data, Gains from Investment Securities came in at $800,000 in FY2013, $9,000 in FY2012 (-87.0%) and $69,000 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 AIM ImmunoTech 3.08 Mn -18.22 Mn 21,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 -189,000.00
API Access

AIM ImmunoTech Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=AIM&period=max&api_key=YOUR_API_KEY